The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.

Autor: Feichtenschlager, Valentin1,2 (AUTHOR) valentin.feichtenschlager@hotmail.com, Chen, Linan1 (AUTHOR), Zheng, Yixuan James1,3 (AUTHOR), Ho, Wilson1 (AUTHOR), Sanlorenzo, Martina1 (AUTHOR), Vujic, Igor1,2,4 (AUTHOR), Fewings, Eleanor1 (AUTHOR), Lee, Albert1 (AUTHOR), Chen, Christopher1 (AUTHOR), Callanan, Ciara1 (AUTHOR), Lin, Kevin1 (AUTHOR), Qu, Tiange5 (AUTHOR), Hohlova, Dasha1,6 (AUTHOR), Vujic, Marin1,2 (AUTHOR), Hwang, Yeonjoo7 (AUTHOR), Lai, Kevin1 (AUTHOR), Chen, Stephanie1 (AUTHOR), Nguyen, Thuan1 (AUTHOR), Muñoz, Denise P7 (AUTHOR), Kohwi, Yoshinori5 (AUTHOR)
Zdroj: Molecular Cancer. 2/22/2024, Vol. 23 Issue 1, p1-21. 21p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje